As filed with the Securities and Exchange Commission on February 26, 2002
Registration No. 333-82012
- --------------------------------------------------------------------------------
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
----------------------
POST-EFFECTIVE AMENDMENT NO. 1
TO
FORM S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
----------------------
ZYMOGENETICS, INC.
(Exact name of registrant as specified in its charter)
WASHINGTON 91-1144498
(State or other jurisdiction of (I.R.S. Employer Identification No.)
incorporation or organization)
1201 EASTLAKE AVENUE E.
SEATTLE, WA 98102
(206) 442-6600
(Address, including zip code, and telephone number,
including area code of principal executive offices)
AMENDED AND RESTATED 2000 STOCK INCENTIVE PLAN
2001 STOCK INCENTIVE PLAN
(Full title of the plan)
JAMES A. JOHNSON
SENIOR VICE PRESIDENT, CHIEF FINANCIAL OFFICER
AND TREASURER
ZYMOGENETICS, INC.
1201 EASTLAKE AVENUE E.
SEATTLE, WA 98102
(206) 442-6600
(Name, address and telephone number, including area code, of agent for service)
----------------------
COPIES TO:
ANDREW BOR
PERKINS COIE LLP
1201 THIRD AVENUE, SUITE 4800
SEATTLE, WASHINGTON 98101-3099
(206) 583-8888
----------------------
POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8
ZymoGenetics, Inc., a Washington corporation (the "Registrant"), is filing this
Post-Effective Amendment No. 1 to the Registration Statement on Form S-8
(Registration No. 333-82012) of the Registrant for the sole purpose of
correcting a typographical error in the I.R.S. Employer Identification No.
("EIN") on the cover page of the Registration Statement on Form S-8 filed with
the Securities and Exchange Commission on February 1, 2002. The correct EIN of
the Registrant is 91-1144498.
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, as amended, the
Registrant certifies that it has reasonable grounds to believe that it meets all
the requirements for filing on Form S-8 and has duly caused this Post-Effective
Amendment No. 1 to the Registration Statement to be signed on its behalf by the
undersigned, thereunto duly authorized, in the City of Seattle, State of
Washington, on the 25th day of February, 2002.
ZYMOGENETICS, INC.
By: /s/ James A. Johnson
----------------------------------------
James A. Johnson
Senior Vice President, Chief Financial
Officer and Treasurer
Pursuant to the requirements of the Securities Act of 1933, as amended, this
Post-Effective Amendment No. 1 to the Registration Statement has been signed by
the following persons in the capacities indicated below on the 25th day of
February, 2002.
SIGNATURE TITLE
Bruce L. A. Carter* President,
- ---------------------------------------------- Chief Executive Officer, and Director
Bruce L. A. Carter, Ph.D. (Principal Executive Officer)
/s/ James A. Johnson Senior Vice President,
- ---------------------------------------------- Chief Financial Officer and Treasurer
James A. Johnson (Principal Accounting and Financial Officer)
George B. Rathman*
- ----------------------------------------------
George B. Rathman, Ph.D. Chairman of the Board of Directors
David I. Hirsh*
- ----------------------------------------------
David I. Hirsh, Ph.D. Director
Jonathan S. Leff*
- ----------------------------------------------
Jonathan S. Leff Director
Kurt Anker Nielsen*
- ----------------------------------------------
Kurt Anker Nielsen Director
Edward E. Penhoet*
- ----------------------------------------------
Edward E. Penhoet, Ph.D. Director
Lori F. Rafield*
- ----------------------------------------------
Lori F. Rafield, Ph.D. Director
Lars Rebien Sorensen*
- ----------------------------------------------
Lars Rebien Sorensen Director
*By: /s/ James A. Johnson
------------------------------------------
James A. Johnson
(Attorney-In-Fact)